Home LiteratureArticle Details
PMID: 18410688 Published · epublish English Journal Article

Engineering BioBrick vectors from BioBrick parts.

Journal of biological engineering ·Vol. 2 ·2008-04-14 ·Pages 5

Shetty RP, Endy D, Knight TF

Abstract

The underlying goal of synthetic biology is to make the process of engineering biological systems easier. Recent work has focused on defining and developing standard biological parts. The technical standard that has gained the most traction in the synthetic biology community is the BioBrick standard for physical composition of genetic parts. Parts that conform to the BioBrick assembly standard are BioBrick standard biological parts. To date, over 2,000 BioBrick parts have been contributed to, and are available from, the Registry of Standard Biological Parts. Here we extended the same advantages of BioBrick standard biological parts to the plasmid-based vectors that are used to provide and propagate BioBrick parts. We developed a process for engineering BioBrick vectors from BioBrick parts. We designed a new set of BioBrick parts that encode many useful vector functions. We combined the new parts to make a BioBrick base vector that facilitates BioBrick vector construction. We demonstrated the utility of the process by constructing seven new BioBrick vectors. We also successfully used the resulting vectors to assemble and propagate other BioBrick standard biological parts. We extended the principles of part reuse and standardization to BioBrick vectors. As a result, myriad new BioBrick vectors can be readily produced from all existing and newly designed BioBrick parts. We invite the synthetic biology community to (1) use the process to make and share new BioBrick vectors; (2) expand the current collection of BioBrick vector parts; and (3) characterize and improve the available collection of BioBrick vector parts.

Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Shetty Reshma P
Department of Biological Engineering, MIT, 32 Vassar Street Rm 32-311, Cambridge, MA 02139, USA. rshetty@mit.edu.
Endy Drew
Knight Thomas F
References (52)
52 references, click to expand
  1. Origin of transferable drug-resistance factors in the enterobacteriaceae.
    Br Med J. 1965 Nov 27;2(5473):1289-91 PMID: 5321597
  2. Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid.
    J Bacteriol. 1978 Jun;134(3):1141-56 PMID: 149110
  3. New ccdB positive-selection cloning vectors with kanamycin or chloramphenicol selectable markers.
    Gene. 1995 Aug 30;162(1):159-60 PMID: 7557407
  4. NOMAD: a versatile strategy for in vitro DNA manipulation applied to promoter analysis and vector design.
    Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10891-6 PMID: 8855278
  5. Cloning and analysis of strong promoters is made possible by the downstream placement of a RNA termination signal.
    Proc Natl Acad Sci U S A. 1981 Aug;78(8):4936-40 PMID: 6946440
  6. Differential plasmid rescue from transgenic mouse DNAs into Escherichia coli methylation-restriction mutants.
    Proc Natl Acad Sci U S A. 1990 Jun;87(12):4645-9 PMID: 2162051
  7. Refactoring bacteriophage T7.
    Mol Syst Biol. 2005;1:2005.0018 PMID: 16729053
  8. Human ORFeome version 1.1: a platform for reverse proteomics.
    Genome Res. 2004 Oct;14(10B):2128-35 PMID: 15489335
  9. Directed evolution of a genetic circuit.
    Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16587-91 PMID: 12451174
  10. Replication control in a composite plasmid constructed by in vitro linkage of two distinct replicons.
    Nature. 1976 Jan 29;259(5541):285-90 PMID: 765836
  11. Cell killing by the F plasmid CcdB protein involves poisoning of DNA-topoisomerase II complexes.
    J Mol Biol. 1992 Aug 5;226(3):735-45 PMID: 1324324
  12. Synthetic biology: designs on life.
    Nature. 2005 Nov 24;438(7067):417-8 PMID: 16306958
  13. A new bacteriophage P1-derived vector for the propagation of large human DNA fragments.
    Nat Genet. 1994 Jan;6(1):84-9 PMID: 8136839
  14. Infective heredity of multiple drug resistance in bacteria.
    Bacteriol Rev. 1963 Mar;27:87-115 PMID: 13999115
  15. Revised interpretation of the origin of the pSC101 plasmid.
    J Bacteriol. 1977 Nov;132(2):734-7 PMID: 334752
  16. Environmental signal integration by a modular AND gate.
    Mol Syst Biol. 2007;3:133 PMID: 17700541
  17. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors.
    Gene. 1985;33(1):103-19 PMID: 2985470
  18. Synthetic biology: engineering Escherichia coli to see light.
    Nature. 2005 Nov 24;438(7067):441-2 PMID: 16306980
  19. A totally synthetic plasmid for general cloning, gene expression and mutagenesis in Escherichia coli.
    Gene. 1990 Sep 28;94(1):103-7 PMID: 2227445
  20. Positive-selection vectors using the F plasmid ccdB killer gene.
    Gene. 1994 Oct 11;148(1):71-4 PMID: 7926841
  21. Synthetic biology. Microbes made to order.
    Science. 2004 Jan 9;303(5655):158-61 PMID: 14715986
  22. Construction of biologically functional bacterial plasmids in vitro.
    Proc Natl Acad Sci U S A. 1973 Nov;70(11):3240-4 PMID: 4594039
  23. Analysis of gene control signals by DNA fusion and cloning in Escherichia coli.
    J Mol Biol. 1980 Apr;138(2):179-207 PMID: 6997493
  24. Episome-mediated transfer of drug resistance in Enterobacteriaceae. I. Transfer of resistance factors by conjugation.
    J Bacteriol. 1961 May;81:669-78 PMID: 13783344
  25. Bacteriophage lambda having EcoRI endonuclease sites only in the nonessential region of the genome.
    Proc Natl Acad Sci U S A. 1974 Oct;71(10):3927-30 PMID: 4530273
  26. Vectors for selective expression of cloned DNAs by T7 RNA polymerase.
    Gene. 1987;56(1):125-35 PMID: 3315856
  27. Construction of improved M13 vectors using oligodeoxynucleotide-directed mutagenesis.
    Gene. 1983 Dec;26(1):101-6 PMID: 6323249
  28. [Preparation of functioning recombinant (hybrid) DNA molecules in vitro (genetic engineering experiments)].
    Genetika. 1975;11(11):34-45 PMID: 776738
  29. Transcription from efficient promoters can interfere with plasmid replication and diminish expression of plasmid specified genes.
    EMBO J. 1982;1(11):1399-404 PMID: 6327267
  30. A Gateway-based platform for multigene plant transformation.
    Plant Mol Biol. 2006 Dec;62(6):927-36 PMID: 16941206
  31. ORFeome cloning and systems biology: standardized mass production of the parts from the parts-list.
    Genome Res. 2004 Oct;14(10B):2001-9 PMID: 15489318
  32. The ecology of transferable drug resistance in the enterobacteria.
    Annu Rev Microbiol. 1968;22:131-80 PMID: 4879515
  33. [Bacterial resistance factors as vectors for gene manipulation and gene therapy (author's transl)].
    MMW Munch Med Wochenschr. 1975 Jun 13;117(24):1051-60 PMID: 177861
  34. The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers.
    Gene. 1982 Oct;19(3):259-68 PMID: 6295879
  35. GeneDesign: rapid, automated design of multikilobase synthetic genes.
    Genome Res. 2006 Apr;16(4):550-6 PMID: 16481661
  36. Plasmid ColEl as a molecular vehicle for cloning and amplification of DNA.
    Proc Natl Acad Sci U S A. 1974 Sep;71(9):3455-9 PMID: 4610576
  37. Homing endonucleases: keeping the house in order.
    Nucleic Acids Res. 1997 Sep 1;25(17):3379-88 PMID: 9254693
  38. Transcription increases the deletion frequency of long CTG.CAG triplet repeats from plasmids in Escherichia coli.
    Nucleic Acids Res. 1997 Jul 15;25(14):2861-8 PMID: 9207036
  39. Genome construction between bacterial species in vitro: replication and expression of Staphylococcus plasmid genes in Escherichia coli.
    Proc Natl Acad Sci U S A. 1974 Apr;71(4):1030-4 PMID: 4598290
  40. Positive selection of recombinant DNA by CcdB.
    Biotechniques. 1996 Aug;21(2):320-3 PMID: 8862819
  41. Charon phages: safer derivatives of bacteriophage lambda for DNA cloning.
    Science. 1977 Apr 8;196(4286):161-9 PMID: 847462
  42. Gene regulation at the single-cell level.
    Science. 2005 Mar 25;307(5717):1962-5 PMID: 15790856
  43. Foundations for engineering biology.
    Nature. 2005 Nov 24;438(7067):449-53 PMID: 16306983
  44. Concerted assembly and cloning of multiple DNA segments using in vitro site-specific recombination: functional analysis of multi-segment expression clones.
    Genome Res. 2004 Oct;14(10B):2111-20 PMID: 15489333
  45. GATEWAY recombinational cloning: application to the cloning of large numbers of open reading frames or ORFeomes.
    Methods Enzymol. 2000;328:575-92 PMID: 11075367
  46. Construction and characterization of new cloning vehicles. II. A multipurpose cloning system.
    Gene. 1977;2(2):95-113 PMID: 344137
  47. Control of segregation of chromosomal DNA by sex factor F in Escherichia coli. Mutants of DNA gyrase subunit A suppress letD (ccdB) product growth inhibition.
    J Mol Biol. 1992 May 5;225(1):39-52 PMID: 1316444
  48. Genetic parts to program bacteria.
    Curr Opin Biotechnol. 2006 Oct;17(5):548-57 PMID: 16978856
  49. DNA cloning using in vitro site-specific recombination.
    Genome Res. 2000 Nov;10(11):1788-95 PMID: 11076863
  50. Independent and tight regulation of transcriptional units in Escherichia coli via the LacR/O, the TetR/O and AraC/I1-I2 regulatory elements.
    Nucleic Acids Res. 1997 Mar 15;25(6):1203-10 PMID: 9092630
  51. C. elegans ORFeome version 1.1: experimental verification of the genome annotation and resource for proteome-scale protein expression.
    Nat Genet. 2003 May;34(1):35-41 PMID: 12679813
  52. USER friendly DNA engineering and cloning method by uracil excision.
    Nucleic Acids Res. 2007;35(6):1992-2002 PMID: 17341463
Article Info
Journal
Journal of biological engineering
Abbr.
J Biol Eng
ISSN
1754-1611
Published
2008-04-14
Epub
2008-00-14
Pages
5
Language
English
Region
England
NLM ID
101306640
PMCID
PMC2373286
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com